Isoform Specific Effects of Mef2C during Direct Cardiac Reprogramming.

Area of Science:

• Cardiovascular Research
• Stem Cell Biology
• Regenerative Medicine

Background:

• Direct conversion of cardiac fibroblasts into induced cardiomyocytes (iCMs) is a promising strategy for heart disease treatment.
• Reprogramming efficiency using the MGT (Mef2c, Gata4, Tbx5) factors varies across studies.
• The role of different Mef2c isoforms in iCM reprogramming efficiency is not well understood.

Purpose of the Study:

• To investigate the impact of Mef2c isoforms (Mi2 and Mi4) on fibroblast to iCM reprogramming efficiency.
• To determine if Mef2c isoform choice contributes to the variability in iCM reprogramming outcomes.
• To explore the potential of Hand2 co-expression to enhance iCM conversion.

Main Methods:

• Fibroblasts were reprogrammed into iCMs using Mef2c isoforms (Mi2, Mi4) with Gata4 and Tbx5.
• Experiments utilized separate vectors and a polycistronic MGT construct.
• Hand2 was added to assess its effect on reprogramming efficiency.

Main Results:

• The Mef2c Mi2 isoform demonstrated higher reprogramming efficiency compared to the Mi4 isoform in mouse embryonic fibroblasts (MEFs).
• Co-expression of Hand2 with MGT factors or Mi2-GT further enhanced iCM conversion rates.
• This study highlights the isoform-specific effects of Mef2c in the reprogramming process.

Conclusions:

• Mef2c isoform selection significantly impacts the efficiency of induced cardiomyocyte generation.
• The findings help explain discrepancies in reprogramming efficiency reported in different laboratories.
• This research may stimulate further investigation into alternative splicing and variant roles in cell fate determination for cardiac regeneration.